Amyl Therapeutics
amyltx.com
BiotechHealthcare
Amyl Therapeutics is a biotechnology company developing a platform to treat diseases linked to amyloid fibrils, targeting neurodegenerative conditions.
Founded
2020
Total Funding
$10M+
Total Rounds
2
First Raise
Jun 3, 2021
Latest Raise
Sep 1, 2026
Get notified when Amyl Therapeutics and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
Showing 1 of 2 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/1/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Amyl Therapeutics 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free